Wish we could get some scoop on why the change of team members
Specifically the change out of Dr. Ottavio Vitolo
This from the 2017 PR upon his joining the team...
Dr. Vitolo is a neuropsychiatrist and researcher with extensive pre-clinical and clinical research experience in both academic and industry settings. Previously has held positions of increasing responsibility at Pfizer, including senior medical director and head of neuromuscular clinical research as well as head of implementation for rare neuromuscular disease programs targeting treatments for diseases including Duchenne muscular dystrophy, Huntington's disease and schizophrenia. He was also formerly associate medical director of discovery research at Shire Human Genetic Therapies. He is currently assistant psychiatrist at Massachusetts General Hospital, instructor in psychiatry at Harvard Medical School, and vice president for clinical development at Homology Medicines, Inc., a private biotechnology company focused on gene therapy and gene editing for rare diseases.
Relmada doesn't hire slouches...
He left in March
On March 6, 2020, Dr. Ottavio Vitolo, who served as Relmada’s Chief Medical Officer and Head of Research and Development, left the company to pursue other opportunities
Could be as simple as the demands on his time...he might not be a stay in one place for very long type of guy...professional disagreement...
Market Data 
Markets 
AI
